Literature DB >> 29542024

Guillain-Barré syndrome: rare extra-intestinal manifestation of hepatitis B.

Amey Dilip Sonavane1, Sanjiv Saigal2, Abhishek Kathuria2, Narendra S Choudhary2, Neeraj Saraf2.   

Abstract

Extrahepatic syndromes are uncommon manifestations of acute and chronic hepatitis B. The pathogenesis likely involves an aberrant immunologic response to extrahepatic viral proteins. Antiviral therapy reduces the availability of these viral protein antigens and thus halts immune activation. Approximately 1% of all cases of acute inflammatory demyelinating polyneuropathy are associated with hepatitis B. Guillain-Barre syndrome (GBS) is a remarkably clinically diverse disorder with distinctive variants characterised by an immune-mediated attack to components of the peripheral nervous system. In this report, we present a rare case of GBS with chronic hepatitis B that resolved with antiviral and intravenous immunoglobulin therapy.

Entities:  

Keywords:  Extrahepatic syndrome; Guillain–Barré syndrome; Hepatitis B

Mesh:

Substances:

Year:  2018        PMID: 29542024     DOI: 10.1007/s12328-018-0847-3

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  11 in total

1.  Gulliane Barre syndrome following vaccination with hepatitis B vaccine.

Authors:  N K Seti; R Reddi; I Anand; P K Sethi
Journal:  J Assoc Physicians India       Date:  2002-07

2.  A rare case of acute hepatitis B virus infection causing guillain-barré syndrome.

Authors:  Kidist K Yimam; Raphael B Merriman; R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-02

Review 3.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

4.  Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen.

Authors:  N Tsukada; C S Koh; A Inoue; N Yanagisawa
Journal:  J Neurol Sci       Date:  1987-02       Impact factor: 3.181

Review 5.  Guillain-Barré syndrome following hepatitis B vaccination.

Authors:  M Khamaisi; Y Shoenfeld; H Orbach
Journal:  Clin Exp Rheumatol       Date:  2004 Nov-Dec       Impact factor: 4.473

Review 6.  Guillain-Barré syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B.

Authors:  E Tabor
Journal:  J Med Virol       Date:  1987-03       Impact factor: 2.327

7.  Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).

Authors:  Nizar Souayah; Abu Nasar; M Fareed K Suri; Adnan I Qureshi
Journal:  J Clin Neuromuscul Dis       Date:  2009-09

8.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

9.  Guillain-Barré syndrome complicating acute hepatitis B. A case with detailed electrophysiological and immunological studies.

Authors:  J R Berger; R Ayyar; W A Sheremata
Journal:  Arch Neurol       Date:  1981-06

10.  Acute hepatitis B presenting as Guillain-Barré syndrome.

Authors:  Gautam Ray; Bhaskar Ghosh; Rahul Bhattacharyya
Journal:  Indian J Gastroenterol       Date:  2003 Nov-Dec
View more
  4 in total

1.  Reactivation of Chronic Hepatitis C as a Potential Trigger for Guillain-Barré Syndrome.

Authors:  Ogochukwu Molokwu; Brittany M Young; Manjit Singh; Krishe Menezes; Raza Mian
Journal:  Cureus       Date:  2019-07-26

2.  Effect of Electromyographic Biofeedback Therapy on Muscle Strength Recovery in Children with Guillain-Barré Syndrome.

Authors:  Qianqian Liu; Jianhua Xue; Pingping Zhao; Yue Ling; Suzhe Liu; Yakun Du; Ning Han; Mingxia Liu; Wei Di
Journal:  J Healthc Eng       Date:  2021-12-23       Impact factor: 2.682

Review 3.  SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.

Authors:  Shahrzad Shoraka; Maria Lucia Brito Ferreira; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

Review 4.  Severe Guillain-Barré syndrome associated with chronic hepatitis B: A case report and literature review.

Authors:  Jiajun Wei; Shenhan Duan
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.